MyAllergy 295+ Advanced allergy mapping for complete relief.
1100 AEDThe Next Generation in Allergy Diagnostics
MyAllergy 295+ is an advanced
solid-phase immunoassay using
nano-particle-coupled allergen extracts and molecular allergens arranged on a microarray.
It includes:
- 295 allergens, including
178 molecular components
- Broader diagnostic capability for complex or cross-reactive allergies
- Enhanced precision for personalized treatment plans
This state-of-the-art test allows clinicians to offer evidence-based, targeted therapy by identifying both primary and cross-reactive sensitizations.